Haemonetics Corporation Detailed Financials

Full historical quarterly statements

Metric2026-03-282025-12-272025-09-272025-06-282025-03-312024-12-282024-09-282024-06-29
Total Revenue346.4M339.0M327.3M321.4M330.6M348.5M345.5M336.2M
Cost of Goods Sold148.1M147.6M143.9M129.5M148.7M148.6M154.3M156.9M
Gross Profit198.2M191.4M183.4M191.9M181.9M199.9M191.2M179.3M
R&D Expenses14.4M14.3M14.5M16.3M16.0M15.8M14.1M14.4M
Operating Expenses146.8M121.8M116.1M138.0M130.5M140.9M139.5M139.5M
Operating Income51.4M69.6M67.3M53.9M51.5M59.0M51.7M39.8M
Other Income / Gains-79.8M-9.6M-16.0M-8.7M19.3M-9.1M-7.0M7.0M
Net Income-20.1M44.7M38.7M34.0M58.0M37.5M33.8M38.4M
EPS (Diluted)-0.440.960.810.711.170.750.660.75
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.5720.5650.560.5970.550.5740.5530.533
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses121.8M107.6M101.6M0114.5M000
Other Expenses10.5M00121.7M0125.1M125.4M125.1M
Cost And Expenses294.9M269.4M260.0M267.5M279.1M289.5M293.8M296.4M
Interest Income00001.4M007.0M
Interest Expense5.4M8.1M7.2M4.1M09.1M7.0M0
Depreciation And Amortization027.4M28.3M28.8M28.2M29.0M29.2M29.1M
Ebitda51.4M96.9M95.5M93.7M79.7M95.1M89.0M80.1M
Ebitdaratio0.1490.2860.2920.2920.2410.2730.2580.238
Operating Income Ratio0.1490.2050.2060.1680.1560.1690.150.118
Income Before Tax-28.4M60.0M51.3M45.2M70.7M49.9M44.7M46.7M
Income Before Tax Ratio-0.0820.1770.1570.1410.2140.1430.1290.139
Income Tax Expense-8.3M15.2M12.6M11.1M12.8M12.4M10.9M8.3M
Net Income Ratio-0.0580.1320.1180.1060.1750.1080.0980.114
Epsdiluted-0.440.950.810.701.170.740.660.74
Weighted Average Shs Out46.2M46.8M47.6M48.1M49.2M50.3M50.9M50.9M
Weighted Average Shs Out Dil46.2M47.0M47.7M48.4M49.5M50.6M51.2M51.6M